2 Phase Use Of Educational Materials In Head And Neck Cancer Center
NCT02204631 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2017-05-25
Summary
The goal of this study is to assess the experience of our patients with head and neck cancer in regard to the information they receive, their symptoms, and their understanding of their diagnosis, to determine ways to improve upon these aspects of patient care in the future.
Conditions
Interventions
- OTHER
-
Head and Neck Educational Handbook
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Lori Wirth, MD · Massachusetts General Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-08-12
- Primary Completion
- 2016-12-22
- Completion
- 2016-12-22
Countries
- United States
Study Locations
More Related Trials
-
Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer
NCT03032250 ·Status: COMPLETED ·Phase: NA
-
Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC
NCT02047201 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Survivorship Care Plans in Head and Neck Cancer
NCT03106090 ·Status: TERMINATED ·Phase: NA
-
Individualized Follow-Up for Head and Neck Cancer
NCT05386225 ·Status: RECRUITING
-
Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy
NCT01627093 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer
NCT04666428 ·Status: COMPLETED
-
A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab
NCT01435252 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer
NCT01098669 ·Status: COMPLETED
-
Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck
NCT01952821 ·Status: COMPLETED
-
Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers
NCT02628912 ·Status: WITHDRAWN
-
Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck Cancer
NCT00840814 ·Status: COMPLETED
-
Comprehensive Assessment of Head and Neck Cancer Survivors
NCT01222481 ·Status: COMPLETED
-
A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer
NCT01693718 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Evaluation for Head and Neck Surgery Branch Studies
NCT00011492 ·Status: TERMINATED
-
Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer
NCT02031250 ·Status: COMPLETED ·Phase: PHASE2
-
Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC)
NCT07225725 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prognostic Value of CTC in HNSCC Patients
NCT01884129 ·Status: TERMINATED
-
Change in Symptom Clusters in HNC Patients
NCT03356093 ·Status: COMPLETED
-
Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas
NCT02279459 ·Status: COMPLETED
-
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer
NCT02567383 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma: a Phase II Clinical Trial
NCT04929067 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
NCT05544136 ·Status: RECRUITING ·Phase: PHASE2
-
Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer
NCT00226239 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer
NCT00713219 ·Status: COMPLETED ·Phase: PHASE2
-
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma
NCT03422536 ·Status: COMPLETED ·Phase: PHASE2